Deep learning-based prediction of the T cell receptor–antigen binding specificity
Top Cited Papers
- 23 September 2021
- journal article
- research article
- Published by Springer Nature in Nature Machine Intelligence
- Vol. 3 (10) , 864-875
Abstract
Neoantigens play a key role in the recognition of tumour cells by T cells; however, only a small proportion of neoantigens truly elicit T-cell responses, and few clues exist as to which neoantigens are recognized by which T-cell receptors (TCRs). We built a transfer learning-based model named the pMHC–TCR binding prediction network (pMTnet) to predict TCR binding specificities of the neoantigens—and T cell antigens in general—presented by class I major histocompatibility complexes. pMTnet was comprehensively validated by a series of analyses and exhibited great advances over previous works. By applying pMTnet to human tumour genomics data, we discovered that neoantigens were generally more immunogenic than self-antigens, but human endogenous retrovirus E (a special type of self-antigen that is reactivated in kidney cancer) is more immunogenic than neoantigens. We further discovered that patients with more clonally expanded T cells that exhibit better affinity against truncal rather than subclonal neoantigens had more favourable prognosis and treatment response to immunotherapy in melanoma and lung cancer but not in kidney cancer. Predicting TCR–neoantigen/antigen pairing is one of the most daunting challenges in modern immunology; however, we achieved an accurate prediction of the pairing using only the TCR sequence (CDR3β), antigen sequence and class I major histocompatibility complex allele, and our work revealed unique insights into the interactions between TCRs and major histocompatibility complexes in human tumours, using pMTnet as a discovery tool.Keywords
Funding Information
- UT | University of Texas MD Anderson Cancer Center (Lung Cancer Moon Shot, Institutional Research Grant)
- The Waun Ki Hong Lung Cancer Research Fund Exon 20 Group Rexanna’s Foundation for Fighting Lung Cancer
- Cancer Prevention and Research Institute of Texas (RP190208)
- U.S. Department of Health & Human Services | National Institutes of Health (5P30CA142543, R01CA258584)
This publication has 71 references indexed in Scilit:
- ATHLATES: accurate typing of human leukocyte antigen through exome sequencingNucleic Acids Research, 2013
- Highly Divergent T-cell Receptor Binding Modes Underlie Specific Recognition of a Bulged Viral Peptide bound to a Human Leukocyte Antigen Class I MoleculeJournal of Biological Chemistry, 2013
- STAR: ultrafast universal RNA-seq alignerBioinformatics, 2012
- LoFreq: a sequence-quality aware, ultra-sensitive variant caller for uncovering cell-population heterogeneity from high-throughput sequencing datasetsNucleic Acids Research, 2012
- Comprehensive genomic characterization of squamous cell lung cancersNature, 2012
- Strelka: accurate somatic small-variant calling from sequenced tumor–normal sample pairsBioinformatics, 2012
- A framework for variation discovery and genotyping using next-generation DNA sequencing dataNature Genetics, 2011
- ANNOVAR: functional annotation of genetic variants from high-throughput sequencing dataNucleic Acids Research, 2010
- Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1Nature, 2009
- Fast and accurate short read alignment with Burrows–Wheeler transformBioinformatics, 2009